Skip to main content
رجوع
Watch Compare

ABVC BIOPHARMA, INC.

جودة البيانات: 100%
ABVC
Nasdaq Manufacturing Chemicals
KWD 1.38
▼ KWD 0.05 (-3.17%)
القيمة السوقية: 35.25 M
السعر
KWD 1.38
القيمة السوقية
35.25 M
نطاق اليوم
KWD 1.31 — KWD 1.42
نطاق 52 أسبوعًا
KWD 0.81 — KWD 5.48
حجم التداول
235,758
فتح KWD 1.37
متوسط 50 يوم / 200 يوم
KWD 1.49
7.44% below
متوسط 50 يوم / 200 يوم
KWD 2.45
43.83% below

Quick Summary

النقاط الرئيسية

Revenue grew 9.40% annually over 5 years — modest growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -2.99 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.40%

النمو

Revenue Growth (5Y)
9.40%
أعلى من متوسط القطاع (9.35%)
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-82.94%
أقل من متوسط القطاع (-51.02%)
ROIC-43.36%
Net Margin-1551.95%
Op. Margin-1403.34%

الأمان

Debt / Equity
0.07
أقل من متوسط القطاع (0.33)
Current Ratio0.63
Interest Coverage-1296.46

التقييم

PE (TTM)
-4.46
أقل من متوسط القطاع (-1.98)
P/B Ratio2.92
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -4.5 -2.0
P/B 2.9 5.1
ROE % -82.9 -51.0
Net Margin % -1552.0 -150.2
Rev Growth 5Y % 9.4 9.3
D/E 0.1 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) 82.84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9.40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 509,589.0 Net Income (TTM) -7.91 M
ROE -82.94% ROA -42.27%
Gross Margin 99.85% Operating Margin -1403.34%
Net Margin -1551.95% Free Cash Flow (TTM) -2.99 M
ROIC -43.36% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.07 Current Ratio 0.63
Interest Coverage -1296.46 Asset Turnover 0.03
Working Capital -2.43 M Tangible Book Value 12.06 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.46 Forward P/E N/A
P/B Ratio 2.92 P/S Ratio 69.18
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.47%
Market Cap 35.25 M Enterprise Value 35.87 M
Per Share
EPS (Diluted TTM) -0.39 Revenue / Share 0.02
FCF / Share -0.12 OCF / Share -0.12
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 37.76%
SBC-Adj. FCF -5.74 M Growth Momentum -9.40

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 509,589.0 509,589.0 152,430.0 969,783.0 355,797.0
Net Income -7.91 M -4.90 M -10.52 M -16.42 M -12.04 M
EPS (Diluted) -0.39 -0.42 -2.43 -0.50 -0.51
Gross Profit 508,826.0 508,826.0 -149,607.0 683,368.0 350,711.0
Operating Income -7.15 M -4.71 M -8.22 M -15.11 M -11.71 M
EBITDA — — — — —
R&D Expenses 121,085.0 179,272.0 1.06 M 2.69 M 1.00 M
SG&A Expenses 2.89 M 2.26 M 5.37 M 6.07 M 5.75 M
D&A — — — 23,799.0 —
Interest Expense 5,516.0 1.31 M 2.49 M 293,968.0 227,210.0
Income Tax 24,154.0 -110,539.0 256,006.0 797,778.0 825,024.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 21.06 M 7.54 M 14.49 M 9.86 M 13.70 M
Total Liabilities 7.76 M 6.82 M 6.36 M 6.62 M 4.83 M
Shareholders' Equity 11.11 M 1.23 M 8.39 M 3.10 M 8.84 M
Total Debt 755,512.0 840,252.0 899,250.0 1.89 M 1.64 M
Cash & Equivalents 681,480.0 248,382.0 60,155.0 85,265.0 5.83 M
Current Assets 2.50 M 2.18 M 1.66 M 2.99 M 9.63 M
Current Liabilities 6.16 M 6.56 M 5.93 M 5.82 M 3.69 M